Welcome to the Grossgold Clinic Cancer Care for Chronic Disease in Clearwater Florida. I am a Cardiologist practicing medicine for 42 years. I cured myself of cancer in 2000. I´m dedicated to the best science-based peer-reviewed medicine specializing in cancer, Lyme disease (ILADS member) and complex chronic disease.
We perform new personalized genomic cancer testing utilizing the RGCC Test. I have been using this test since 2006. At that time, I cured my father of bladder cancer utilizing the results of this test. Many different new vaccines are now available for your cancer success.
The treatment of Lyme disease is integrative. Over 25 years I have developed a successful treatment plan tailored for each patient.
Thank you for visiting my website and if you should have any questions please call us at :
Cancer Testing and Treatment
We are Specialized in the following Diseases.
Personalized Cancer Testing
New personalized, molecular genomic DNA testing for detection, prognosis, therapy, and cancer prevention. New “tailor-made” personalized treatment programs based on your cancer genome and
Cancer Metastasis
The analysis of your cancer genome represents a powerful tool to identify effective chemotherapy and mechanisms of resistance and eventual chemotherapy failure Targeted therapies to reduce
Immunotherapy
The use of checkpoint inhibitors, autologous tumor vaccines, Dendritic cell vaccines with immune optimization. Unleash the power of your immune system. It has revolutionized the treatment…
Chemotherapy
Targeted molecular low-dose chemotherapy based on chemosensitivity and natural substances testing. Low dose metronomic chemotherapy based on your chemosensitivity testing
In 2006 my father had a bladder cancer and he was getting the wrong chemotherapy and he was getting it a traditional high dose. I attended a medical meeting and met the owner of RGCC Group. He described a test where he could measure the amount of circulating cancer in the blood as well as determine which chemotherapy and which natural substances worked best. I performed the testing and found that my dad was getting ineffective chemotherapy. I switched to chemotherapy according to the test results and gave it to him in low doses, so he did not have side effects. He also received natural substances intravenously. Six months later my dad was cured of his cancer. Over the years I did intermittent blood testing and he remained negative. I periodically have testing and continue to be negative for cancer.
Research genetic cancer Center (RGCC) is a world class laboratory specializing in cancer genetics and circulating tumor counts. It focuses on molecular oncology. Every year the test panels are expanding and every year there are new vaccines now available for our cancer patients. The testing allows for early detection and diagnosis of new cancers, sometimes years before most cancers would be detected. It allows for the monitoring of the existing cancers as well as gives a prognosis concerning the recurrence of disease.
Additional testing includes chemosensitivity testing to identify which chemotherapy drug demonstrates the most effective to each individual patient. Testing is also performed to identify chemo resistance. This is the identification of chemotherapy drugs that will not be as effective for each individual patient.
Assessment of natural substances and plant extracts against each patient’s cancer is tested for. These natural substances are synergistic with the low dose chemotherapy.
I feel that immune function is very important in all patients but especially cancer patients. This is a test that I feel is necessary in each patient. Repairing immune function gives better outcomes and success.
In addition, the test evaluates 72 tumor related genes and for resistant factors that I use in formulating a personalized treatment plan.
Tumor free means that there are no active tumors that are found on ultrasound, x-ray, CAT scan, MRI, or PET scanning. In addition, or your blood markers are negative or within normal limits. Unfortunately, this is the term used in a large majority of cases. The patient is then told to watch and wait. If it comes back, then generally the patient is on palliative care or get another round of high-dose chemotherapy. This is sometimes accompanied with immunotherapy if indicated.
Cancer free includes everything from the tumor free plus there is no circulating cancer in your blood. The only normal level should be 0. I have monitored people over the years and the goal is to reach 0 and stay there. Maintaining a proactive approach is the key to success.
According to “Cancer growth metastasis” 2015 volume 8 metastasis frequently exists prior to the detection of the primary tumor. In addition, metastatic cells may reside in organs in the original host that are not usually the site of detectable secondary tumors. The problem is that metastatic cells can remain dormant for decades after the primary tumor has been removed. Adding to the problem is that dormancy might be reversible and lead to later recurrences. This being the problem it is important to obtain testing from RGCC on a periodic basis.
According to “Cancer growth metastasis” 2015 volume 8 metastasis frequently exists prior to the detection of the primary tumor. In addition, metastatic cells may reside in organs in the original host that are not usually the site of detectable secondary tumors. The problem is that metastatic cells can remain dormant for decades after the primary tumor has been removed. Adding to the problem is that dormancy might be reversible and lead to later recurrences. This being the problem it is important to obtain testing from RGCC on a periodic basis.
Types of Cancer We Treat
Brain Cancer
The cancer genome atlas research network has provided new insights into the personalized genomics mutations that drive disease
Breast Cancer
World wide breast cancer is the most frequently diagnosed cancer and the leading cause of death among females. Measure your ne
Colon Cancer
Measure your genomic “driver mutations” and block these critical pathways using targeted low-dose targeted chemotherapy
Kidney Cancer
It is anticipated that in the future kidney cancer will soon become a chronic disorder as we understand the cancer genome.
Lung Cancer
Lung cancer is the leading cause of cancer-related deaths in the United States. Non-small cell lung cancer represents 80%,
Lymphoma
For Hodgkin lymphoma and non-Hodgkin’s lymphoma, new testing allows us to target cancer mutations using low-dose chemotherapy,
Melanoma
The genetic and molecular understanding of melanoma is transforming its treatment. Measure your molecular mutational drivers
Ovarian Cancer
Gynecological cancer research is changing the way we treat ovarian cancer. We can now measure the molecular pathways and block these
Pancreatic Cancer
We can now offer patients promising new therapies based on the new revolutionary genome at testing. By evaluating your cancer biomarkers,
Uterine Cancer
Endometrial cancer is the most common gynecologic malignancy. With new genomic biomarkers, we can develop personalized programs,
Other Cancer
Please call us for an in-depth discussion of your cancer and the treatment modalities from around the world available here